3.

Results of MY09/11 consensus PCR and type-specific PCRs and overview of follow-up for different cytological groups

MY09/11 PCR	+					−									+													−
Type-specific PCRs	+					+									−													−
HPV	HR-HPV					HR-HPV									HPV X													Negative
Initial diagnosis	N	Follow-up				CIN2+	n	Follow-up								CIN2+	n	Follow-up												CIN2+	N	Follow-up																CIN2+
%			n				n					%							n								n									%											n												n													%															n																n
Squamous lesions
Negative	401	11.2	367	80	42	8.6	34	6	1, 776	28.9	1, 349	0	2, 142	38.6	1, 626	1
ASC-US	1, 217	33.8	1, 069	173	186	37.9	142	24	2, 965	48.3	2, 253	2	2, 861	51.6	2, 166	0
ASC-H	93	2.6	81	17	25	5.1	23	8	139	2.3	107	0	62	1.1	49	1
L-SIL	1, 418	39.4	1, 357	265	170	34.6	142	20	995	16.2	762	2	251	4.5	193	1
H-SIL	427	11.9	356	236	54	11.0	54	40	107	1.7	86	7	17	0.3	16	1
Glandular lesions
AGC	40	1.1	18	0	14	2.9	14	6	159	2.6	122	0	213	3.8	164	0
Total	3,596	100	3,248	771	491	100	409	104	6,141	100	4,679	11	5, 546	100	4,214	4
Follow-up	%			90.3					%							83.3									%											76.2													%															76.0
CIN2+	%			23.7					%							25.4									%											0.2													%															0.1